The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The Hidden Risks of BPC157: What Patients Need to Know About Contamination and Safety Regenexx at New Regeneration Orthopedics BPC 157: Miracle Healing Peptide or Hidden Danger? The Peptide Ban Is Ending: FDA Peptides Explained Apple Podcasts RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion